Skip to main content

Table 1 Baseline characteristics of the study population

From: A functional variant rs12904 in the miR-200c binding site was associated with a decreased risk of ischemic stroke

Variables Controls, n = 331 Patients with IS, n = 328 P value
Age, years (± SD) 60.8 (± 11.2) 62.0 (± 11.4) 0.18
Male/ Female (%) 217 (65.6)/ 114 (34.4) 232 (70.7)/ 96 (29.3) 0.15
Hypertension, yes/no (%) 62 (18.7)/269 (81.3) 172 (52.4)/156 (47.6) <  0.001
Type 2 diabetes, yes/no (%) 26 (7.9)/305 (92.1) 47 (14.3)/281 (85.7) 0.008
Smoking, yes/no (%) 86 (26.0)/245 (74.0) 101 (30.8)/227 (69.2) 0.17
TC, mmol/L 4.77 ± 0.78 4.67 ± 1.13 0.19
TG, mmol/L 1.33 ± 0.80 1.82 ± 1.57 <  0.001
HDL-C, mmol/L 1.52 ± 0.39 1.14 ± 0.33 <  0.001
LDL-C, mmol/L 2.34 ± 0.99 2.94 ± 0.95 <  0.001
VLDL-C, mmol/L 0.68 ± 0.50 0.85 ± 0.69 <  0.001
Apo-A1, g/L 1.77 ± 1.09 1.24 ± 0.26 <  0.001
Apo-B, g/L 0.76 ± 0.30 1.00 ± 0.30 <  0.001
  1. IS ischemic stroke, SD standard deviation, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, VLDL-C very low-density lipoprotein cholesterol, Apo-A1 apolipoprotein A1; Apo-B apolipoprotein B